Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem that will touch nearly 30 percent more people globally in the next three decades. Though new approaches to managing SCD have led to improvements in diagnosis and supportive care, people living with the disease still have severe complications to overcome. Many are unable to access quality care and are limited by a lack of effective treatment options.
In an effort to identify unmet medical needs for people with SCD, the American Society of Hematology (ASH), along with other groups, issued the State of Sickle Cell Disease: 2016 Report, evaluating the disease in four priority areas — access to care, training and professional education, research and clinical trials, and global health. The report shows that significant improvements are needed across all areas and that, though patients are living longer, the system of care needs to change to ensure a better quality of life. To address these challenges, ASH launched the Sickle Cell Disease Coalition along with more than 20 other organizations who are issuing a call to action that will amplify the voice of the SCD community, promote SCD awareness, and transform SCD care both in the United States and around the globe.
To view the multimedia release go to:
http://www.multivu.com/players/English/7903251-american-society-hematology-sickle-cell-coalition/
Leveraging 130 years of knowledge and expertise across the Johnson & Johnson Family of Companies, Johnson & Johnson Medical Devices (JJMD) is proud to launch a new approach to help drive value-based healthcare in hospitals across Europe, Middle East and Africa (EMEA) – CareAdvantage. This is a data-driven, holistic approach in which JJMD partners with hospitals and other healthcare providers to provide a range of benefits, tailored to the customer’s specific needs and priorities.
The healthcare marketplace is changing, with intensifying pressure to meet the ‘triple aim’ of improving outcomes, increasing patient satisfaction and reducing costs. As the focus shifts from volume to value, there is a growing need for new delivery models, resulting in rapid transformation for hospital systems, clinicians and their patients.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8119051-johnson-medical-devices-careadvantage/
Janssen Healthcare Innovation, a team within Janssen Research & Development, LLC (Janssen), today announced Discharge Decision Support System (D2S2) is the winner of the crowdsourcing-inspired Janssen Connected Care Challenge and the $100,000 prize. D2S2 is a discharge decision support system that uses a proprietary algorithm to assemble and score key data upon hospital admission in order to identify patients who should be referred to post-acute care services to reduce the risk of 30-day readmissions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56342-discharge-decision-support-system-janssen-connected-care-challenge
Children with physical disabilities are twice as likely to be bullied, impacting their educational, physical and emotional development.* In support of National Bullying Prevention Month this October, Shriners Hospitals for Children® and award-winning actor, model and philanthropist, RJ Mitte, are once again partnering to encourage the public to help #CutTheBull.
Teens and adults alike are encouraged to visit CutTheBull.org and see how they can help create a more positive, accepting environment for kids living with disabilities. There, Shriners Hospitals will announce “RJ's Heroes”, honoring individuals who have helped reduce bullying in their communities. Supporters can also share their anti-bullying stories and purchase #CutTheBull t-shirts, with proceeds going to Shriners Hospitals for Children to provide life-changing care to kids.
Born with cerebral palsy, Mitte was bullied as a child and knows firsthand the effects it can have. The doctors and staff at Shriners Hospitals for Children helped Mitte overcome many of the physical effects of cerebral palsy, which made him stronger and able to succeed despite the bullying. Now a successful actor and model, Mitte wants to help other kids with disabilities who may be experiencing the same thing.
To view the multimedia release go to:
http://www.multivu.com/players/English/7559151-shriners-hospital-cut-the-bull/
Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial) diarrhoea in industrialised countries.2 In a report launched today, during a meeting hosted by the European Healthcare and Hospital Federation (HOPE), experts from across Europe highlight the current deficiencies in the management of CDI and outline the steps that are needed to address them.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60637-astellas-report-diagnosis-management-CDI
M@gic$imp$on1 Production$ 2012
Undercover police officers, Magic Simpson and Chad Holland attend a blood member funeral who was killed in a gang driveby shooting at White Rock Missionary Baptist Church in Houston, Texas on Darien Street. They were hired as the funeral security and must protect the church from the crip gang. Drae and Charlie respond to a street fight in process between two gang members. A blood and crip. Jenny whose partner was killed in a shootout with car theft suspects save a three month year old baby after a truck was on fire. The mother has died and the baby was rushed to Texas children memorial hospital for medical treatment where he almost died from his injuries. The war between bloods and crips will never end. If you are interested in reading what the characters are saying watch it on YouTube.
A level IV trauma center in Washington State has installed copper components throughout its facility as another way of reducing hospital-acquired infections and keeping their patients safe.
Pullman Regional Hospital has become an early adopter of antimicrobial copper after studies found that the age-old metal could continuously kill deadly bacteria.
Each year, 2 million people in the United States are diagnosed with a hospital-acquired infection and nearly 100,000 people die. These infections are caused by common bacteria such as E. coli, MRSA, C. diff, CRE and VRE.
“It is a very serious problem,” said Ed Harrich, the director of surgical services for Pullman Regional Hospital. “I think every hospital across the nation is doing everything they can to try to deal with it the best that they can. But there’s bioburden on everything and people aren’t good at hand washing and there’s cross-contamination everywhere you go.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378651-copper-development-association-cda-pullman-regional-hospital-keep-patients-safe-antimicrobial-copper/
The Centers for Medicare & Medicaid Services (CMS) has launched a nationwide public outreach campaign – including a letter to doctors and a new public service announcement – to raise awareness about the preventive benefits now covered at no charge to Medicare beneficiaries as a result of the Affordable Care Act. The campaign will run throughout the summer, with online ads and community events all over the country starting in July. As part of the Share the News, Share the Health campaign, CMS recently upgraded its dedicated caregivers’ website Ask Medicare, including a link to prevention information for caregivers’ reference.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cms/49739/
Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53686-cord-blood-childrens-memorial-hermann-fda-approved-stem-cells-hearing-loss
LeBron James. Stephen Curry. The Goodyear Blimp. The Chosen One. The Unanimous MVP. The World Famous Icon.
Three undeniable greats with one common bond – all were “Akron Born.”
With the world’s greatest basketball players set to compete on the sport’s biggest stage, The Goodyear Tire & Rubber Company will celebrate their birthplace by getting the next generation of Akron greats off to a winning start.
To do this, Goodyear will honor babies born in Akron-area hospitals during the NBA Finals with a “Most Valuable Ride” care package consisting of a set of Goodyear tires, an “AkronBorn” onesie and a brand-new infant car seat.
Three Akron-based medical facilities – Summa Akron City Hospital, Cleveland Clinic Akron General and Akron Children’s Hospital – will “assist” the initiative and help deliver the care packages to families of newborns. The package builds on Goodyear’s recent Safe Mobility Project with Akron Children’s Hospital.
To view the multimedia release go to:
http://www.multivu.com/players/English/7833452-goodyear-celebrates-great-things-akron/
One of every ten euros of the gross domestic product is gained through health care. And, despite Germanys image of being a nation of motorists actually the most patents are filed in the medical field. It is therefore no wonder that German Chancellor Angela Merkel paid a visit to the world's largest medical trade fair MEDICA in Duesseldorf. Also present was the Minister of health Dr. Philipp Rösler, who prepared for the upcoming tasks at the Hospital day which runs parallel to the fair.
New findings from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project (PCGP) have helped identify the mechanism that makes the childhood eye tumor retinoblastoma so aggressive. The discovery explains why the tumor develops so rapidly while other cancers can take years or even decades to form.
The finding also led investigators to a new treatment target and possible therapy for the rare childhood tumor of the retina, the light-sensing tissue at the back of the eye. The study appears in the January 11 advance online edition of the scientific journal Nature.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46767-st-jude-genome-project-treatment-childhood-eye-tumor-retinoblastoma
